In a regulatory filing, IGM Biosciences disclosed that its director Kathleen Behrens bought 112.5K shares of common stock on June 26th in a total transaction size of $900K.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IGMS:
- IGM Biosciences 3.29M share Spot Secondary priced at $8.00
- IGM Biosciences prices 3.29M shares at $8.00 in underwritten public offering
- IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
- IGM Announces Proposed Public Offering and Concurrent Private Placement
- IGM Biosciences announces $100M common stock offering, private placement